Exploring the Effectiveness of Unpowered Negative Pressure Wound Therapy
NPWT
2 other identifiers
interventional
160
0 countries
N/A
Brief Summary
The aim of this study is to investigate the effectiveness of Non-powered Negative Pressure Wound Therapy (NPWT) on the healing of abdominal surgical wounds. It is designed as a randomized controlled trial with an experimental group (using NPWT) and a control group (conventional wound care). The study aims to recruit 160 participants: 80 with acute wounds and 80 with chronic wounds. Participants will be randomly assigned to either the experimental group (40 acute wounds, 40 chronic wounds) or the control group (40 acute wounds, 40 chronic wounds). The study will assess wound healing rates and speed, quality of life, self-perceived health status, pain levels, complications, and wound care costs using indicators. Effectiveness will be analyzed using Generalized Estimating Equations (GEE). The study anticipates that results will contribute to evaluating the effects of Non-powered NPWT on wound healing, quality of life, pain, and cost-effectiveness in patients with acute and chronic wounds.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started May 2025
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 2, 2025
CompletedFirst Posted
Study publicly available on registry
April 4, 2025
CompletedStudy Start
First participant enrolled
May 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 31, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
March 31, 2026
CompletedApril 4, 2025
February 1, 2025
1 month
March 2, 2025
March 28, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
wound healing
1. Wound size will be measured before and after the intervention, using a ruler and photographic records. 2. The occurrence and time of healing events will be documented. The modified TIME-H score will be used as the evaluation tool. This scoring system includes four main indicators: T (Tissue)、I (Infection)、M (Moisture)、E (Edge)、H (Healing).
90days
Secondary Outcomes (8)
Pain Assessment
90days
Wound-related Quality of Life
90days
Self-reported Health Status
90days
Length of Hospital Stay for wound treatment
90days
Cost Analysis
90days
- +3 more secondary outcomes
Study Arms (2)
NPWT
EXPERIMENTALThe NPWT group (experimental group) will include 80 participants. Wounds will be cleansed with sterile normal saline, followed by wound assessment and documentation. The Anscare SIMO Negative Pressure Wound Therapy (NPWT) System, a non-powered NPWT dressing, will then be applied.
standard care group
OTHERThestandard care group will include 80 participants. Wounds will be cleansed with sterile normal saline and receive routine wound care, followed by wound assessment and documentation.
Interventions
The standard care (SC) group will also include 80 participants. Wounds will be cleansed with sterile normal saline and managed using conventional wound care techniques. Participants will undergo regular postoperative follow-ups to assess wound healing progression and secondary outcome measures.
The NPWT group will also include 80 participants. Wounds will be cleansed with sterile normal saline and coverd the SIMO NPWT dressing. Participants will undergo regular postoperative follow-ups to assess wound healing progression and secondary outcome measures.
Eligibility Criteria
You may qualify if:
- Patients with acute wounds (wound duration \<4 weeks) or chronic wounds (wound duration ≥4 weeks).
- Wound depth \<2 cm.
- Age ≥18 years.
- Patients who have been evaluated and approved for participation by their attending physician.
You may not qualify if:
- Patients with unstable vital signs.
- Presence of ischemia in the wound or surrounding tissues.
- Fragile skin around the wound.
- Severe wound infection or necrotic tissue.
- Wound size \>10 × 20 cm.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Taipei Medical Universitylead
- BenQ Materials Corporationcollaborator
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 2, 2025
First Posted
April 4, 2025
Study Start
May 1, 2025
Primary Completion
May 31, 2025
Study Completion
March 31, 2026
Last Updated
April 4, 2025
Record last verified: 2025-02
Data Sharing
- IPD Sharing
- Will not share
The plan is not public yet.